142 related articles for article (PubMed ID: 2311679)
1. Ibuprofen, a putative anti-cataract drug, protects the lens against cyanate and galactose.
Roberts KA; Harding JJ
Exp Eye Res; 1990 Feb; 50(2):157-64. PubMed ID: 2311679
[TBL] [Abstract][Full Text] [Related]
2. Aspirin prevents carbamylation of soluble lens proteins and prevents cyanate-induced phase separation opacities in vitro: a possible mechanism by which aspirin could prevent cataract.
Crompton M; Rixon KC; Harding JJ
Exp Eye Res; 1985 Feb; 40(2):297-311. PubMed ID: 3979467
[TBL] [Abstract][Full Text] [Related]
3. Bendazac prevents cyanate binding to soluble lens proteins and cyanate-induced phase-separation opacities in vitro: a possible mechanism by which bendazac could delay cataract.
Lewis BS; Rixon KC; Harding JJ
Exp Eye Res; 1986 Dec; 43(6):973-9. PubMed ID: 3817034
[TBL] [Abstract][Full Text] [Related]
4. Reaction of aspirin with cysteinyl residues of lens gamma-crystallins: a mechanism for the proposed anti-cataract effect of aspirin.
Qin W; Smith JB; Smith DL
Biochim Biophys Acta; 1993 Apr; 1181(2):103-10. PubMed ID: 8481398
[TBL] [Abstract][Full Text] [Related]
5. The effects of aminoguanidine on the glycation (non-enzymic glycosylation) of lens proteins.
Lewis BS; Harding JJ
Exp Eye Res; 1990 May; 50(5):463-7. PubMed ID: 2373149
[TBL] [Abstract][Full Text] [Related]
6. The non-enzymic glycosylation of bovine lens proteins by glucosamine and its inhibition by aspirin, ibuprofen and glutathione.
Ajiboye R; Harding JJ
Exp Eye Res; 1989 Jul; 49(1):31-41. PubMed ID: 2759189
[TBL] [Abstract][Full Text] [Related]
7. Investigations of ibuprofen and paracetamol binding to lens proteins to explore their protective role against cataract.
Shyadehi AZ; Harding JJ
Biochem Pharmacol; 1991 Nov; 42(11):2077-84. PubMed ID: 1958225
[TBL] [Abstract][Full Text] [Related]
8. Prevention of cataract in diabetic rats by aspirin, paracetamol (acetaminophen) and ibuprofen.
Blakytny R; Harding JJ
Exp Eye Res; 1992 Apr; 54(4):509-18. PubMed ID: 1623937
[TBL] [Abstract][Full Text] [Related]
9. Aspirin prevents the nonenzymatic glycosylation and carbamylation of the human eye lens crystallins in vitro.
Rao GN; Cotlier E
Biochem Biophys Res Commun; 1988 Mar; 151(3):991-6. PubMed ID: 3355566
[TBL] [Abstract][Full Text] [Related]
10. High galactose levels in vitro and in vivo impair ascorbate regeneration and increase ascorbate-mediated glycation in cultured rat lens.
Saxena P; Saxena AK; Monnier VM
Exp Eye Res; 1996 Nov; 63(5):535-45. PubMed ID: 8994357
[TBL] [Abstract][Full Text] [Related]
11. Non-enzymic glycosylation (glycation) of lens proteins by galactose and protection by aspirin and reduced glutathione.
Huby R; Harding JJ
Exp Eye Res; 1988 Jul; 47(1):53-9. PubMed ID: 3409987
[TBL] [Abstract][Full Text] [Related]
12. Protective effects of ibuprofen and its major metabolites against in vitro inactivation of catalase and fumarase: relevance to cataract.
Shyadehi AZ; Harding JJ
Biochim Biophys Acta; 2002 May; 1587(1):31-5. PubMed ID: 12009421
[TBL] [Abstract][Full Text] [Related]
13. Acetylation of lens crystallins: a possible mechanism by which aspirin could prevent cataract formation.
Rao GN; Lardis MP; Cotlier E
Biochem Biophys Res Commun; 1985 May; 128(3):1125-32. PubMed ID: 4004853
[TBL] [Abstract][Full Text] [Related]
14. Effects of magnesium taurate on the onset and progression of galactose-induced experimental cataract: in vivo and in vitro evaluation.
Agarwal R; Iezhitsa I; Awaludin NA; Ahmad Fisol NF; Bakar NS; Agarwal P; Abdul Rahman TH; Spasov A; Ozerov A; Mohamed Ahmed Salama MS; Mohd Ismail N
Exp Eye Res; 2013 May; 110():35-43. PubMed ID: 23428743
[TBL] [Abstract][Full Text] [Related]
15. The major metabolite of bendazac inhibits the glycosylation of soluble lens proteins: a possible mechanism for a delay in cataractogenesis.
Lewis BS; Harding JJ
Exp Eye Res; 1988 Aug; 47(2):217-25. PubMed ID: 3409993
[TBL] [Abstract][Full Text] [Related]
16. Ibuprofen protects alpha-crystallin against posttranslational modification by preventing protein cross-linking.
Plater ML; Goode D; Crabbe MJ
Ophthalmic Res; 1997; 29(6):421-8. PubMed ID: 9380344
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of 6-phosphogluconate dehydrogenase by carbamylation and protection by alpha-crystallin, a chaperone-like protein.
Ganea E; Harding JJ
Biochem Biophys Res Commun; 1996 May; 222(2):626-31. PubMed ID: 8670255
[TBL] [Abstract][Full Text] [Related]
18. Taurine prevents galactose-induced cataracts.
Malone JI; Benford SA; Malone J
J Diabetes Complications; 1993; 7(1):44-8. PubMed ID: 8481550
[TBL] [Abstract][Full Text] [Related]
19. [New regulatory protein isolated from the bovine eye lens and its action on the cataract development in rat in vitro].
Krasnov MS; Gurmizov EP; Iamskova VP; Gundorova RA; Iamskov IA
Vestn Oftalmol; 2005; 121(1):37-9. PubMed ID: 15759848
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of galactose-induced alterations in ocular lens with sorbinil.
Unakar NJ; Tsui JY
Exp Eye Res; 1983 May; 36(5):685-94. PubMed ID: 6303825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
